Effects of artemether and dihydroarteannuin on mouse model of scleroderma
Ma, J.; Chen, L.; Liao, R.; Xu, S.; Li, M.; Xu, D.; Li, W.
Zhongguo Zhong Yao Za Zhi 34(2): 204-207
2009
ISSN/ISBN: 1001-5302 PMID: 19385187 Document Number: 633410
To study the effects of artemether and dihydroarteannuin on the mouse model of scleroderma. Sixty mice were randomly divided into 8 groups: PBS control group, model group, menstruum group (20% Tween-80, 0.4%CMC-Na), positive medicine group (penicillamine 200 mg kg(-1)), low-dose artemether group (5 mg kg(-1)), high-dose artemether group (20 mg kg(-1)), low-dose dihydroarteannuin group (5 mg kg(-1)), high-dose dihydroarteannuin group (25 mg kg(-1)). We have established a mouse model for scleroderma in Balb/c mice by subcutaneous injections of bleomycin 0.1 mL per day (200 mg L(-1) BLM) for 3 weeks. Meanwhile, the administration lasted for 4 weeks. The back skin was removed in the next day after the final administration. Treated skins and lungs were harvested and analyzed for histological sclerosis. The thickness of the skin and fibrosis degree of derma were observed and made an analysis of the contents of collagen and hydroxyproline. Compared with the model groups, the high-dose groups markedly inhibited the thickness of derma (P<0.001), furthermore, the contents of collagen and hydroxyproline in the skin were also significantly reduced (P<0.05). Other groups of mice showed improvement on scleroderma. Our results suggest that administration of artemether or dihydroarteannuin may be an effective approach in preventing systemic sclerosis.